These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 28407835)

  • 1. [Recurrent pulmonary infection and oral mucosal ulcer].
    Kuang FM; Tang LL; Zhang H; Xie M; Yang MH; Yang LC; Yu Y; Cao LZ
    Zhongguo Dang Dai Er Ke Za Zhi; 2017 Apr; 19(4):452-457. PubMed ID: 28407835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Dyskeratosis congenita: an update].
    Mialou V; Leblanc T; Peffault de Latour R; Dalle JH; Socié G
    Arch Pediatr; 2013 Mar; 20(3):299-306. PubMed ID: 23352883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe immunochemotherapy-induced toxicities in a patient with dyskeratosis congenita and literature review.
    Geng J; Zhao M; Li Q
    Hematology; 2022 Dec; 27(1):1041-1045. PubMed ID: 36073719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allogeneic hematopoietic stem cell transplantation for dyskeratosis congenita.
    Elmahadi S; Muramatsu H; Kojima S
    Curr Opin Hematol; 2016 Nov; 23(6):501-507. PubMed ID: 27607446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Squamous cell carcinoma of the tongue in 5-year-old girl with dyskeratosis congenita.
    Jh K; Cs K
    Int J Oral Maxillofac Surg; 2021 Dec; 50(12):1546-1549. PubMed ID: 33736925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diffuse hemorrhagic colitis in a patient with dyskeratosis congenita after nonmyeloablative allogeneic hematopoietic stem cell transplantation.
    Ehlert K; Rossig C; Groll AH; Beyna T; Froehlich B; Juergens H
    J Pediatr Hematol Oncol; 2015 Jan; 37(1):e41-4. PubMed ID: 25000468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Research progress of dyskeratosis congenita].
    Wang F; Du YQ; Gong W; Sun CK; Zeng X
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2019 Feb; 54(2):130-134. PubMed ID: 30695916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dyskeratosis congenita with a novel genetic variant in the DKC1 gene: a case report.
    Ratnasamy V; Navaneethakrishnan S; Sirisena ND; Grüning NM; Brandau O; Thirunavukarasu K; Dagnall CL; McReynolds LJ; Savage SA; Dissanayake VHW
    BMC Med Genet; 2018 May; 19(1):85. PubMed ID: 29801475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dyskeratosis congenita: A case report on a rare disease.
    Khaliq S; Hasan Kazmi SK
    J Pak Med Assoc; 2021 Mar; 71(3):1007-1010. PubMed ID: 34057965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver Transplant for Management of Hepatic Complications of Dyskeratosis Congenita: A Case Report.
    Alebrahim M; Akateh C; Arnold CA; Benissan-Messan D; Chavez JA; Singh N; Al-Adwan Y; El-Hinnawi A; Michaels A; Black SM
    Exp Clin Transplant; 2022 Jul; 20(7):702-705. PubMed ID: 33272154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Molecular diagnosis and therapeutic measures in patients with dyskeratosis congenita].
    Reiger Z; Varga G; Tóth B; Maródi L; Erdos M
    Orv Hetil; 2010 Feb; 151(8):285-92. PubMed ID: 20153999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dyskeratosis congenita and telomerase.
    Bessler M; Wilson DB; Mason PJ
    Curr Opin Pediatr; 2004 Feb; 16(1):23-8. PubMed ID: 14758110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dyskeratosis congenita associated with leukoplakia of the tongue.
    Noto Z; Tomihara K; Furukawa K; Noguchi M
    Int J Oral Maxillofac Surg; 2016 Jun; 45(6):760-3. PubMed ID: 26778687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and genetic features of dyskeratosis congenita, cryptic dyskeratosis congenita, and Hoyeraal-Hreidarsson syndrome in Japan.
    Yamaguchi H; Sakaguchi H; Yoshida K; Yabe M; Yabe H; Okuno Y; Muramatsu H; Takahashi Y; Yui S; Shiraishi Y; Chiba K; Tanaka H; Miyano S; Inokuchi K; Ito E; Ogawa S; Kojima S
    Int J Hematol; 2015 Nov; 102(5):544-52. PubMed ID: 26329388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dyskeratosis congenita: its connections with oral and maxillofacial surgery.
    Sabesan T; Baheerathan NN; Ilankovan V
    Br J Oral Maxillofac Surg; 2007 Mar; 45(2):156-8. PubMed ID: 16024141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of dyskeratosis congenita with granulocyte-macrophage colony-stimulating factor and erythropoietin.
    Erduran E; Hacisalihoglu S; Ozoran Y
    J Pediatr Hematol Oncol; 2003 Apr; 25(4):333-5. PubMed ID: 12679652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allogeneic Hematopoietic Cell Transplantation for Dyskeratosis Congenita: A Report of 3 Cases.
    Tamura S; Imamura T; Urata T; Kobayashi M; Gen M; Tomii T; Do J; Osone S; Ishida H; Hosoi H; Kuroda H
    J Pediatr Hematol Oncol; 2017 Oct; 39(7):e394-e398. PubMed ID: 28538506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dyskeratosis congenita: a case report.
    Abdel-Karim A; Frezzini C; Viggor S; Davidson LE; Thornhill MH; Yeoman CM
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Aug; 108(2):e20-4. PubMed ID: 19615640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral mucosal manifestations in some genodermatoses: correlation with cutaneous lesions.
    Nico MM; Hammerschmidt M; Lourenço SV
    Eur J Dermatol; 2013; 23(5):581-91. PubMed ID: 24001555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hematopoietic cell transplantation in Fanconi anemia and dyskeratosis congenita: A minireview.
    Ayas M
    Hematol Oncol Stem Cell Ther; 2017 Dec; 10(4):285-289. PubMed ID: 28644950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.